To assess the visual outcomes of patients with Leber hereditary optic neuropathy (LHON) harboring the m.11778G>A MT-ND4 mutation with no treatment (natural history), idebenone therapy, and lenadogene nolparvovec intravitreal injection.
No takes yet. Share an insight, caveat, or question.
Newman et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: